Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial - Baud, O; Maury, L; Lebail, F; PREMILOC Trial Study Group (Lancet, 2016)
(10030):